Logotype for Claritev Corporation

Claritev (CTEV) Q3 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Claritev Corporation

Q3 2026 earnings summary

9 Nov, 2026

Executive summary

  • Q3 revenue was $268.311M, up 9.1% YoY, and Adjusted EBITDA was $161.972M, up 4.4%; results exceeded expectations.

  • ACV bookings were ~$27M in Q3 and ~$101M for 9M; more than 50% of YTD bookings came from outside the core payer market.

  • FY26 guidance was raised, and initial FY27 revenue outlook is at least $1.1B, one year ahead of the prior 2028 target.

Financial highlights

  • Q3 revenue was $268.311M, up 9.1% YoY; 9M revenue was $770.467M, up 7.2%.

  • Q3 Adjusted EBITDA was $161.972M, up 4.4% YoY; margin was 60.4% vs. 63.1% a year earlier.

  • Q3 operating income was $20.627M vs. $10.067M; net loss narrowed to $61.789M from $69.753M, and Adjusted EPS was $1.77.

  • 9M Adjusted EBITDA was $464.685M vs. $451.229M; 9M net loss was $194.575M vs. $203.712M.

  • Q3 operating cash flow was $18.1M and free cash flow was negative $25.8M; unlevered free cash flow was $104.4M.

Outlook and guidance

  • FY26 revenue guidance was raised to $1.038B–$1.043B, with midpoint $30.5M above Q2 guidance.

  • FY26 Adjusted EBITDA guidance was raised to $625M–$630M; free cash flow guidance to $10M–$20M.

  • FY26 CapEx guidance was narrowed to $165M–$170M; effective tax rate guidance is 24%–28%.

  • Initial FY27 revenue outlook is at least $1.1B, one year ahead of the prior 2028 target; detailed segment and cash flow guidance is planned with Q4 results.

  • FY26 ACV bookings are expected at $115M–$125M, up 70%–90% YoY; bookings typically begin converting to revenue in 2–4 quarters.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Claritev